These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 21871133)

  • 41. Hsp90·Cdc37 Complexes with Protein Kinases Form Cooperatively with Multiple Distinct Interaction Sites.
    Eckl JM; Scherr MJ; Freiburger L; Daake MA; Sattler M; Richter K
    J Biol Chem; 2015 Dec; 290(52):30843-54. PubMed ID: 26511315
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Cdc37 facilitates cell survival of colorectal carcinoma via activating the CDK4 signaling pathway.
    Zhu J; Yan F; Tao J; Zhu X; Liu J; Deng S; Zhang X
    Cancer Sci; 2018 Mar; 109(3):656-665. PubMed ID: 29288563
    [TBL] [Abstract][Full Text] [Related]  

  • 43. An activated JAK/STAT3 pathway and CD45 expression are associated with sensitivity to Hsp90 inhibitors in multiple myeloma.
    Lin H; Kolosenko I; Björklund AC; Protsyuk D; Österborg A; Grandér D; Tamm KP
    Exp Cell Res; 2013 Mar; 319(5):600-11. PubMed ID: 23246572
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Serine/Threonine Kinase Unc-51-like Kinase-1 (Ulk1) Phosphorylates the Co-chaperone Cell Division Cycle Protein 37 (Cdc37) and Thereby Disrupts the Stability of Cdc37 Client Proteins.
    Li R; Yuan F; Fu W; Zhang L; Zhang N; Wang Y; Ma K; Li X; Wang L; Zhu WG; Zhao Y
    J Biol Chem; 2017 Feb; 292(7):2830-2841. PubMed ID: 28073914
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Functional Role and Hierarchy of the Intermolecular Interactions in Binding of Protein Kinase Clients to the Hsp90-Cdc37 Chaperone: Structure-Based Network Modeling of Allosteric Regulation.
    Stetz G; Verkhivker GM
    J Chem Inf Model; 2018 Feb; 58(2):405-421. PubMed ID: 29432007
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Novel Hsp90 inhibitor FW-04-806 displays potent antitumor effects in HER2-positive breast cancer cells as a single agent or in combination with lapatinib.
    Huang W; Wu QD; Zhang M; Kong YL; Cao PR; Zheng W; Xu JH; Ye M
    Cancer Lett; 2015 Jan; 356(2 Pt B):862-71. PubMed ID: 25449780
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Mammalian p50Cdc37 is a protein kinase-targeting subunit of Hsp90 that binds and stabilizes Cdk4.
    Stepanova L; Leng X; Parker SB; Harper JW
    Genes Dev; 1996 Jun; 10(12):1491-502. PubMed ID: 8666233
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Stability of the human Hsp90-p50Cdc37 chaperone complex against nucleotides and Hsp90 inhibitors, and the influence of phosphorylation by casein kinase 2.
    Olesen SH; Ingles DJ; Zhu JY; Martin MP; Betzi S; Georg GI; Tash JS; Schönbrunn E
    Molecules; 2015 Jan; 20(1):1643-60. PubMed ID: 25608045
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effective targeting of triple-negative breast cancer cells by PF-4942847, a novel oral inhibitor of Hsp 90.
    Mehta PP; Whalen P; Baxi SM; Kung PP; Yamazaki S; Yin MJ
    Clin Cancer Res; 2011 Aug; 17(16):5432-42. PubMed ID: 21715568
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Design of Disruptors of the Hsp90-Cdc37 Interface.
    D'Annessa I; Hurwitz N; Pirota V; Beretta GL; Tinelli S; Woodford M; Freccero M; Mollapour M; Zaffaroni N; Wolfson H; Colombo G
    Molecules; 2020 Jan; 25(2):. PubMed ID: 31952296
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Cdk2: a genuine protein kinase client of Hsp90 and Cdc37.
    Prince T; Sun L; Matts RL
    Biochemistry; 2005 Nov; 44(46):15287-95. PubMed ID: 16285732
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Analysis of the CK2-dependent phosphorylation of serine 13 in Cdc37 using a phospho-specific antibody and phospho-affinity gel electrophoresis.
    Miyata Y; Nishida E
    FEBS J; 2007 Nov; 274(21):5690-703. PubMed ID: 17922836
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Hsp90 interacts with Cdc37, is phosphorylated by PKA/PKC, and regulates Src phosphorylation in human sperm capacitation.
    Li K; Sun P; Wang Y; Gao T; Zheng D; Liu A; Ni Y
    Andrology; 2021 Jan; 9(1):185-195. PubMed ID: 32656999
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Hsp90/p50cdc37 is required for mixed-lineage kinase (MLK) 3 signaling.
    Zhang H; Wu W; Du Y; Santos SJ; Conrad SE; Watson JT; Grammatikakis N; Gallo KA
    J Biol Chem; 2004 May; 279(19):19457-63. PubMed ID: 15001580
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Heat shock protein 90-sheltered overexpression of insulin-like growth factor 1 receptor contributes to malignancy of thymic epithelial tumors.
    Breinig M; Mayer P; Harjung A; Goeppert B; Malz M; Penzel R; Neumann O; Hartmann A; Dienemann H; Giaccone G; Schirmacher P; Kern MA; Chiosis G; Rieker RJ
    Clin Cancer Res; 2011 Apr; 17(8):2237-49. PubMed ID: 21372220
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Platycodin D inhibits proliferation, migration and induces chemosensitization through inactivation of the NF-κB and JAK2/STAT3 pathways in multiple myeloma cells.
    Wu D; Zhang W; Chen Y; Ma H; Wang M
    Clin Exp Pharmacol Physiol; 2019 Dec; 46(12):1194-1200. PubMed ID: 31347196
    [TBL] [Abstract][Full Text] [Related]  

  • 57. SNX-2112, a novel Hsp90 inhibitor, induces G2/M cell cycle arrest and apoptosis in MCF-7 cells.
    Wang SX; Ju HQ; Liu KS; Zhang JX; Wang X; Xiang YF; Wang R; Liu JY; Liu QY; Xia M; Xing GW; Liu Z; Wang YF
    Biosci Biotechnol Biochem; 2011; 75(8):1540-5. PubMed ID: 21821931
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Molecular Mechanism of Protein Kinase Recognition and Sorting by the Hsp90 Kinome-Specific Cochaperone Cdc37.
    Keramisanou D; Aboalroub A; Zhang Z; Liu W; Marshall D; Diviney A; Larsen RW; Landgraf R; Gelis I
    Mol Cell; 2016 Apr; 62(2):260-271. PubMed ID: 27105117
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Antimyeloma activity of heat shock protein-90 inhibition.
    Mitsiades CS; Mitsiades NS; McMullan CJ; Poulaki V; Kung AL; Davies FE; Morgan G; Akiyama M; Shringarpure R; Munshi NC; Richardson PG; Hideshima T; Chauhan D; Gu X; Bailey C; Joseph M; Libermann TA; Rosen NS; Anderson KC
    Blood; 2006 Feb; 107(3):1092-100. PubMed ID: 16234364
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Targeting Hsp90-Cdc37: A Promising Therapeutic Strategy by Inhibiting Hsp90 Chaperone Function.
    Wang L; Li L; Gu K; Xu XL; Sun Y; You QD
    Curr Drug Targets; 2017; 18(13):1572-1585. PubMed ID: 27231111
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.